{
  "Variants Include": [
    {
      "Gene": "LRRK2",
      "variants": [
        {
          "HGVS": "NM_198578.2:c.4336G>A",
          "cDNA Change": {
            "transcript": "NM_198578.2",
            "ref": "G",
            "alt": "A",
            "position": "4336"
          },
          "Protein Change": {
            "ref": "G",
            "alt": "D",
            "position": "1441"
          },
          "Description in input context": "R1441G"
        },
        {
          "HGVS": "NM_198578.2:c.5095T>G",
          "cDNA Change": {
            "transcript": "NM_198578.2",
            "ref": "T",
            "alt": "G",
            "position": "5095"
          },
          "Protein Change": {
            "ref": "Y",
            "alt": "C",
            "position": "1699"
          },
          "Description in input context": "Y1699C"
        },
        {
          "HGVS": "NM_198578.2:c.6055G>A",
          "cDNA Change": {
            "transcript": "NM_198578.2",
            "ref": "G",
            "alt": "A",
            "position": "6055"
          },
          "Protein Change": {
            "ref": "G",
            "alt": "S",
            "position": "2019"
          },
          "Description in input context": "G2019S"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson’s disease (PD)",
    "MONDO": "MONDO:0004976"
  },
  "Experiment Method": [
    {
      "Assay Method": "Affinity purification and mass spectrometric analysis",
      "Material used": {
        "Material Source": "Mouse brain",
        "Material Name": "LRRK2 purified from mouse brain",
        "Description": "Using affinity purification and mass spectrometric analysis, we investigated phosphorylation sites and binding proteins of LRRK2 purified from mouse brain."
      },
      "Readout type": "Qualitative",
      "Readout description": [
        {
          "Variant": "NM_198578.2:c.4336G>A",
          "Conclusion": "N.D.",
          "Molecular Effect": "N.D.",
          "Result Description": "The study indicates that the common PD-related mutations of LRRK2, R1441G, decrease homeostatic phosphorylation levels of S935 and impair 14-3-3 binding of LRRK2."
        },
        {
          "Variant": "NM_198578.2:c.5095T>G",
          "Conclusion": "N.D.",
          "Molecular Effect": "N.D.",
          "Result Description": "The study indicates that the common PD-related mutations of LRRK2, Y1699C, decrease homeostatic phosphorylation levels of S935 and impair 14-3-3 binding of LRRK2."
        },
        {
          "Variant": "NM_198578.2:c.6055G>A",
          "Conclusion": "N.D.",
          "Molecular Effect": "N.D.",
          "Result Description": "The study indicates that the common PD-related mutations of LRRK2, G2019S, decrease homeostatic phosphorylation levels of S935 and impair 14-3-3 binding of LRRK2."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "N.D."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "N.D."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "N.D."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "N.D.",
        "Source": "N.D."
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "N.D.",
        "Source": "N.D."
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Immunoprecipitation",
      "Material used": {
        "Material Source": "Transfected HEK-293T cells",
        "Material Name": "FLAG-LRRK2",
        "Description": "The anti-pS935 antibody detects a strong signal in purified FLAG-LRRK2 protein from BAC transgenic brains."
      },
      "Readout type": "Qualitative",
      "Readout description": [
        {
          "Variant": "NM_198578.2:c.4336G>A",
          "Conclusion": "N.D.",
          "Molecular Effect": "N.D.",
          "Result Description": "Mutants R1441G and Y1699C isolated from cells have markedly reduced pS935 levels; mutant G2019S and kinase-deficient mutant K1906M did not change significantly in pS935 levels."
        },
        {
          "Variant": "NM_198578.2:c.5095T>G",
          "Conclusion": "N.D.",
          "Molecular Effect": "N.D.",
          "Result Description": "Mutants R1441G and Y1699C isolated from cells have markedly reduced pS935 levels; mutant G2019S and kinase-deficient mutant K1906M did not change significantly in pS935 levels."
        },
        {
          "Variant": "NM_198578.2:c.6055G>A",
          "Conclusion": "N.D.",
          "Molecular Effect": "N.D.",
          "Result Description": "Mutants R1441G and Y1699C isolated from cells have markedly reduced pS935 levels; mutant G2019S and kinase-deficient mutant K1906M did not change significantly in pS935 levels."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "N.D."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "N.D."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "N.D."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "N.D.",
        "Source": "N.D."
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "N.D.",
        "Source": "N.D."
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "GST-pull down assay",
      "Material used": {
        "Material Source": "Bacteria",
        "Material Name": "GST-14-3-3 isoform protein",
        "Description": "GST-14-3-3 isoform protein was expressed in bacteria with 100 mM IPTG induction for 4 hours at 37uC, and purified following the manufacture’s instruction."
      },
      "Readout type": "Qualitative",
      "Readout description": [
        {
          "Variant": "NM_198578.2:c.4336G>A",
          "Conclusion": "N.D.",
          "Molecular Effect": "N.D.",
          "Result Description": "The binding of 14-3-3 to mutant R1441G or Y1699C is markedly reduced as compared to wild type LRRK2, whereas 14-3-3 binding is affected little in G2019S or K1906M mutant."
        },
        {
          "Variant": "NM_198578.2:c.5095T>G",
          "Conclusion": "N.D.",
          "Molecular Effect": "N.D.",
          "Result Description": "The binding of 14-3-3 to mutant R1441G or Y1699C is markedly reduced as compared to wild type LRRK2, whereas 14-3-3 binding is affected little in G2019S or K1906M mutant."
        },
        {
          "Variant": "NM_198578.2:c.6055G>A",
          "Conclusion": "N.D.",
          "Molecular Effect": "N.D.",
          "Result Description": "The binding of 14-3-3 to mutant R1441G or Y1699C is markedly reduced as compared to wild type LRRK2, whereas 14-3-3 binding is affected little in G2019S or K1906M mutant."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "N.D."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "N.D."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "N.D."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "N.D.",
        "Source": "N.D."
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "N.D.",
        "Source": "N.D."
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "PKA kinase assay",
      "Material used": {
        "Material Source": "Bacteria",
        "Material Name": "GST-LRRK2 fragment",
        "Description": "GST-LRRK2 fragment (800–1000aa) was expressed in bacteria with 50 mM IPTG induction at RT for overnight and purified following the manufacture’s instruction."
      },
      "Readout type": "Qualitative",
      "Readout description": [
        {
          "Variant": "NM_198578.2:c.4336G>A",
          "Conclusion": "N.D.",
          "Molecular Effect": "N.D.",
          "Result Description": "PKA phosphorylates S935 as detected with anti-pS935 antibody and that the phosphorylation is enhanced with increased input of PKA amount."
        },
        {
          "Variant": "NM_198578.2:c.5095T>G",
          "Conclusion": "N.D.",
          "Molecular Effect": "N.D.",
          "Result Description": "PKA phosphorylates S935 as detected with anti-pS935 antibody and that the phosphorylation is enhanced with increased input of PKA amount."
        },
        {
          "Variant": "NM_198578.2:c.6055G>A",
          "Conclusion": "N.D.",
          "Molecular Effect": "N.D.",
          "Result Description": "PKA phosphorylates S935 as detected with anti-pS935 antibody and that the phosphorylation is enhanced with increased input of PKA amount."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "N.D."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "N.D."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "N.D."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "N.D.",
        "Source": "N.D."
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "N.D.",
        "Source": "N.D."
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}